Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Irini Schenkel"'
Autor:
Jürgen Debus, David T.W. Jones, Christel Herold-Mende, Gnana Prakash Balasubramanian, Felix Sahm, Andreas Unterberg, Irini Schenkel, Benedikt Brors, Tobias Kessler, Wolfgang Wick, Michael Platten, Stefan M. Pfister, David Capper, Andreas von Deimling, Antje Wick, Anne Berberich, Susan Dettmer, Daniel Schrimpf, Martin Bendszus, Elke Pfaff, Andreas Eisenmenger
Background O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is a predictive biomarker in glioblastoma patients. Glioblastoma without hypermethylated MGMT promoter is largely resistant to treatment with temozolomide. These pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e73948e7f065d70815121cf103d573
https://europepmc.org/articles/PMC5961072/
https://europepmc.org/articles/PMC5961072/
Publikováno v:
Psychosomatics. 47:62-67
This is the first study that investigates the responsiveness of the Patient Health Questionnaire-9 (PHQ-9), a standard 9-item self-report depression scale, to antidepressant medication. Authors analyzed data from 1,788 depressed outpatients (66.8% wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf71ac0868ef570e84cabefb24bdd2c4
https://doi.org/10.1176/appi.psy.47.1.62
https://doi.org/10.1176/appi.psy.47.1.62
Publikováno v:
Journal of Affective Disorders. 87:271-279
It is well established that subjects participating in controlled clinical trials may not be representative of patients seen in actual practice. Given that efficacy and safety of sertraline have been investigated almost exclusively in controlled clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a634de9c888adb8d714f8321483eaa
https://doi.org/10.1016/j.jad.2005.05.005
https://doi.org/10.1016/j.jad.2005.05.005
Autor:
Oliver Schnell, Marion Laumann, Astrid Weyerbrock, J. Hense, Martin Misch, Theresa Bunse, Angela Hueckelhoven, Ghazaleh Tabatabai, Felix Sahm, Stefan Stevanovic, Daniela Schilling, Michael Platten, Anita Schmitt, Andreas von Deimling, Wolfgang Wick, Michael Schmitt, Irini Schenkel, Joachim P. Steinbach, Dietmar Krex, Martin Bendszus
Publikováno v:
Journal of Clinical Oncology. 34:TPS2082-TPS2082
TPS2082Background: Mutations in the gene for isocitrate dehydrogenase type 1 frequently occur in diffuse gliomas resulting in a point mutation (IDH1R132H) in most of the cases. Preclinical studies have shown that mutation-specific T helper (Th) cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33568b2d344885a13e2c52d459066d5d
https://doi.org/10.1200/jco.2016.34.15_suppl.tps2082
https://doi.org/10.1200/jco.2016.34.15_suppl.tps2082